Vasopressin (USP)
CHEBI:CHEBI_9937
Definition
A family of cyclic nonapeptide hormones found in most mammals. Synthesised in the hypothalamus and stored in the post-pituitary, vasopressins play a key role in homeostasis, particularly in regulating the body's water content. Together with the similar neuropeptide oxytocin, they are believed to influence social cognition and behaviour.
Chemical Information
- Molecular Formula
- C46H65N15O12S2.C46H65N13O12S2
- Molecular Mass
- 2140.458
- Charge
- 0
Alternative Names
- argipressin
- ADH
- arginine vasopressin
- AVP
- VP
- Antidiuretic hormone
- beta-Hypophamine
- Inyectable de vasopresina
- Solute injectable de vasopressine
- Vasopressin
- Vasopressini injectio
Treatment Applications
-
hydranencephalyView Disease →
DOID:4626
Drug Classification
-
peptide hormoneView Class →
CHEBI:25905
-
heterodetic cyclic peptideView Class →
CHEBI:24533
-
argipressinView Class →
CHEBI:34543
-
ArgipressinView Class →
CHEBI:34543
Important Medical Information
⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.
- Always consult with a healthcare professional before starting, stopping, or modifying any medication.
- Side effects may vary and this list may not be comprehensive.
- Drug interactions may occur with other medications.
Additional Identifiers
- oboInOwl#hasDbXref
- PMID:20445498
- DRON_00010000
- 11149
- core#notation
- CHEBI:9937
Additional References
🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.
Additional Attributes
- oboInOwl#hasOBONamespace
- chebi_ontology
- oboInOwl#hasDbXref
- PMID:20445498
- DRON_00010000
- 11149
- oboInOwl#id
- CHEBI:9937
- brand_name
- Vasostrict
- brand_name_base
- Vasostrict
- generic_name
- Vasopressin in 0.9% Sodium Chloride
- product_type
- BULK INGREDIENT
- marketing_category
- BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
- dosage_form
- INJECTION, SOLUTION
- labeler_name
- PolyPeptide Laboratories (Sweden) AB
- product_ndc
- 35207-0005
- application_number
- ANDA211857
- oboInOwl#inSubset
- http://purl.obolibrary.org/obo/chebi#3_STAR
- listing_expiration_date
- 20241231
- marketing_start_date
- 20181117
- route
- INTRAVENOUS
- spl_id
- 3d63e1df-6636-4cf8-9b1e-1b91231f6bc4
- package_ndc
- 41701-008-70
- core#notation
- CHEBI:9937
- nui
- N0000009908
- upc
- 0355150370009
- pharm_class_pe
- Decreased Diuresis [PE]
- pharm_class
- Vasopressins [CS]
- pharm_class_cs
- Vasopressins [CS]
- 22-rdf-syntax-ns#type
- http://www.w3.org/2002/07/owl#Class
- rxcui
- 2670683
- manufacturer_name
- Long Grove Pharmaceuticals, LLC
- active_ingredient_name
- VASOPRESSIN, UNSPECIFIED
- active_ingredient_strength
- 2.7 g/2.7g
- unii
- Y87Y826H08
- spl_set_id
- d162d386-105d-e916-e053-2995a90a350c
- package_marketing_start_date
- 20220831
- package_description
- 1 BOTTLE, PLASTIC in 1 PACKAGE (41701-008-70) / 2.7 g in 1 BOTTLE, PLASTIC (41701-008-69)
- has_treatment
- http://purl.obolibrary.org/obo/DOID_12070
- rdf-schema#range
- https://w3id.org/def/predibionto#has_drug_111007
- rdf-schema#domain
- https://w3id.org/def/predibionto#has_side_effect21923
- owl#annotatedSource
- t324735
- owl#someValuesFrom
- t510418